通过专为投资者打造的一站式数据看板，全面查看 Foghorn Therapeutics Inc. 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值

211.36M

股息TTM

0.00

市盈率 TTM

-3.09

每股收益TTM

-1.17

营业收入

30.91M

净利润

-86.62M

净资产收益率

-470.38%

总资产收益率

-31.33%

Foghorn Therapeutics Inc. 财报日历

财务报表摘要

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

财务指标

每股收益

64.25%-0.10

4.63%-0.29

-10.74%-0.34

17.68%-0.25

36.07%-0.28

49.17%-0.30

45.65%-0.31

10.51%-0.31

36.81%-0.45

19.14%-0.59

17.39%-0.57

---0.34

---0.70

---0.73

---0.69

---1.93

----

营业收入

112.68%16.07M

-45.11%3.27M

223.77%9.25M

4.42%8.15M

9.71%7.56M

17.86%5.95M

-50.49%2.86M

-55.33%7.81M

23.02%6.89M

-4.88%5.05M

37.88%5.77M

163.46%17.48M

24.70%5.60M

35.43%5.31M

486.82%4.18M

16080.49%6.63M

1509.32%4.49M

1270.63%3.92M

184.06%713.00K

-77.09%41.00K

净利润

59.91%-7.19M

-5.53%-19.88M

-11.08%-21.66M

17.12%-15.85M

21.95%-17.94M

24.71%-18.83M

19.09%-19.50M

-33.30%-19.12M

22.07%-22.98M

17.95%-25.02M

16.55%-24.11M

44.33%-14.35M

-7.96%-29.49M

-13.28%-30.49M

0.88%-28.89M

1.19%-25.77M

-18.18%-27.31M

-17.09%-26.91M

-40.39%-29.14M

-41.99%-26.08M

利润率

81.15%-44.74%

-92.26%-608.36%

65.69%-234.28%

20.62%-194.39%

28.86%-237.34%

36.12%-316.43%

-63.43%-682.88%

-198.39%-244.90%

36.65%-333.61%

13.74%-495.37%

39.48%-417.85%

---82.07%

---526.65%

---574.27%

---690.39%

---531.75%

----

毛利率

0.00%100.00%

--100.00%

----

利润表

营业收入

112.68%16.07M

-45.11%3.27M

223.77%9.25M

4.42%8.15M

9.71%7.56M

17.86%5.95M

-50.49%2.86M

-55.33%7.81M

23.02%6.89M

-4.88%5.05M

37.88%5.77M

163.46%17.48M

24.70%5.60M

35.43%5.31M

486.82%4.18M

16080.49%6.63M

1509.32%4.49M

1270.63%3.92M

184.06%713.00K

-77.09%41.00K

营业利润

58.26%-8.80M

5.85%-21.57M

18.37%-19.60M

22.43%-18.50M

12.94%-21.10M

18.73%-22.91M

5.71%-24.00M

-39.64%-23.85M

24.39%-24.23M

15.38%-28.19M

20.16%-25.46M

39.56%-17.08M

-9.81%-32.05M

-19.83%-33.32M

-13.55%-31.89M

-7.61%-28.26M

-25.48%-29.19M

-20.21%-27.80M

-35.15%-28.08M

-42.04%-26.26M

净利润

59.91%-7.19M

-5.53%-19.88M

-11.08%-21.66M

17.12%-15.85M

21.95%-17.94M

24.71%-18.83M

19.09%-19.50M

-33.30%-19.12M

22.07%-22.98M

17.95%-25.02M

16.55%-24.11M

44.33%-14.35M

-7.96%-29.49M

-13.28%-30.49M

0.88%-28.89M

1.19%-25.77M

-18.18%-27.31M

-17.09%-26.91M

-40.39%-29.14M

-41.99%-26.08M

资产负债表

流动资产

-16.58%170.05M

-16.57%188.06M

-34.60%163.24M

-32.12%184.12M

-29.62%203.84M

6.57%225.42M

3.92%249.60M

2.18%271.23M

-0.30%289.62M

-34.04%211.52M

-31.65%240.18M

-29.73%265.44M

-27.39%290.49M

-25.39%320.70M

-23.54%351.40M

204.76%377.76M

176.53%400.07M

160.00%429.82M

141.00%459.56M

59.40%123.95M

流动负债总额

-34.98%50.58M

-9.68%64.40M

-10.82%59.74M

49.74%85.09M

52.91%77.79M

36.96%71.31M

14.64%66.99M

9.25%56.82M

-10.18%50.87M

-6.69%52.06M

5.85%58.44M

-5.79%52.01M

18.08%56.64M

15.66%55.80M

13.38%55.20M

186.12%55.21M

192.22%47.97M

195.39%48.24M

158.37%48.69M

-9.41%19.30M

总资产

-10.10%203.39M

-14.12%222.17M

-30.24%198.10M

-33.53%204.96M

-31.15%226.24M

1.45%258.69M

-0.68%283.98M

-1.61%308.37M

-3.24%328.58M

-31.61%255.00M

-29.38%285.92M

-27.77%313.42M

-25.68%339.58M

-23.64%372.88M

-22.10%404.88M

133.21%433.93M

119.11%456.90M

112.41%488.31M

103.36%519.77M

30.64%186.07M

总负债

-6.09%284.43M

-6.80%298.57M

-6.95%306.60M

-12.49%294.62M

-11.67%302.89M

-9.12%320.34M

-9.25%329.51M

-9.21%336.66M

-11.83%342.91M

-11.32%352.49M

-10.29%363.11M

-9.47%370.81M

-4.97%388.93M

-4.43%397.47M

-4.29%404.77M

289.78%409.61M

292.26%409.27M

297.15%415.90M

286.54%422.90M

5.78%105.09M

总权益

-5.72%-81.04M

-23.93%-76.41M

-138.31%-108.50M

-216.96%-89.66M

-435.25%-76.66M

36.76%-61.65M

41.02%-45.53M

50.71%-28.29M

70.98%-14.32M

-296.51%-97.49M

-69019.64%-77.19M

-335.94%-57.39M

-203.61%-49.35M

-133.96%-24.59M

-99.88%112.00K

-69.96%24.32M

-54.28%47.63M

-42.16%72.40M

-33.73%96.87M

87.97%80.98M

现金流量表

经营净额

15.03%-17.84M

-5.42%-25.27M

9.17%-22.27M

10.21%-18.86M

17.77%-21.00M

18.32%-23.97M

10.97%-24.52M

22.80%-21.00M

20.63%-25.54M

5.89%-29.34M

4.78%-27.54M

-36.15%-27.21M

-10.90%-32.17M

-111.48%-31.18M

-343.43%-28.92M

2.52%-19.99M

-56.97%-29.01M

1273.09%271.53M

211.52%11.88M

-852.09%-20.50M

投资净额

-108.77%-2.97M

-160.27%-17.72M

-40.64%13.23M

158.02%35.57M

288.23%33.83M

8.51%29.40M

-40.37%22.29M

-259.57%-61.31M

-145.93%-17.98M

-8.17%27.09M

674.54%37.38M

-16.56%38.43M

131.44%39.13M

118.51%29.50M

-167.27%-6.51M

197.30%46.05M

-261.45%-124.46M

-4788.35%-159.41M

109.65%9.67M

-772.41%-47.33M

融资净额

-108.66%-22.00K

35707.19%49.77M

14425.00%581.00K

-95.34%49.00K

-99.75%254.00K

-88.09%139.00K

-97.85%4.00K

-24.22%1.05M

100100.00%103.21M

1044.12%1.17M

1062.50%186.00K

316.52%1.39M

-90.00%103.00K

-73.44%102.00K

-99.93%16.00K

-34.06%333.00K

827.93%1.03M

519.35%384.00K

-83.08%21.74M

-98.76%505.00K

常见问题

Foghorn Therapeutics Inc.的总收入是多少？



根据Foghorn Therapeutics Inc.的FY2025财报，总收入达到了30.91M（同比变化22.60M）。

Foghorn Therapeutics Inc.的流动资产是多少？



根据Foghorn Therapeutics Inc.的FY2025财报，流动资产为163.24M（同比变化-34.60）。

Foghorn Therapeutics Inc.的总资产是多少？



根据Foghorn Therapeutics Inc.的FY2025财报，Foghorn Therapeutics Inc.的总资产为198.10M（同比变化-30.24）。

Foghorn Therapeutics Inc.的总负债是多少？



根据Foghorn Therapeutics Inc.的FY2025财报，Foghorn Therapeutics Inc.的总负债为306.60M（同比变化-6.95）。

Foghorn Therapeutics Inc.的总权益是多少？



根据Foghorn Therapeutics Inc.的FY2025财报，Foghorn Therapeutics Inc.的总权益为-108.50M（同比变化-138.31）。

Foghorn Therapeutics Inc.的净营业收入是多少？



根据Foghorn Therapeutics Inc.的FY2025财报，Foghorn Therapeutics Inc.的净营业收入为-82.11M（同比变化18.13）。

Foghorn Therapeutics Inc.的净投资是多少？



根据Foghorn Therapeutics Inc.的FY2025财报，Foghorn Therapeutics Inc.的净投资为112.04M（同比变化474.67）。

Foghorn Therapeutics Inc.的净融资是多少？



根据Foghorn Therapeutics Inc.的FY2025财报，Foghorn Therapeutics Inc.的净融资为1.02M（同比变化-99.03）。

Foghorn Therapeutics Inc.的每股收益（EPS）是多少？



根据Foghorn Therapeutics Inc.的FY2025财报，每股收益（EPS）为-1.18（同比变化25.25）。

Foghorn Therapeutics Inc.的净利润是多少？



根据Foghorn Therapeutics Inc.的FY2025财报，净利润为-74.28M（同比变化14.24）。

Foghorn Therapeutics Inc.的净利润率是多少？



根据Foghorn Therapeutics Inc.的FY2025财报，净利润率为-240.33（同比变化37.29）。

Foghorn Therapeutics Inc.的资产回报率（ROA）是多少？



根据Foghorn Therapeutics Inc.的FY2025财报，资产回报率（ROA）为-30.82（同比变化-1.38）。

Foghorn Therapeutics Inc.的营业利润是多少？



根据Foghorn Therapeutics Inc.的FY2025财报，营业利润为-82.11M（同比变化18.13）。